Correspondence
Psoriasis treated with ustekinumab in a patient with hepatitis C
First published: 17 February 2013
No abstract is available for this article.
References
- 1Prignano F,
Zanieri F,
Milani S,
Lotti T.
Switch from etanercept to efalizumab in a psoriatic patient with HCV infection: a case report.
Dermatol Ther2009; 22: 386–390.
- 2Richetta A,
Maiani E,
Carlomagno V,
et al.
Treatment of erythrodermic psoriasis in HCV+ patient with adalimumab.
Dermatol Ther2009; 22: S16–S18.
- 3Chien Al,
Elder JT,
Ellis CN.
Ustekinumab: a new option in psoriasis therapy.
Drugs2009; 69: 1141–1152.
- 4Kanazawa K,
Aikawa T,
Tsuda F,
Okamoto H.
Hepatitis C virus infection in patients with psoriasis.
Arch Dermatol1996; 132: 1391.
- 5Paradisi A,
Caldarola G,
Capazzi R,
et al.
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data.
J Am Acad Dermatol2010; 62: 1067–1069.
